Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-050256

Chief Executive Officer sold 7,800 shares at an average $39.35 ($306,923)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-09-06 Sale −2,780 $38.45 $106,891 71,498 I
Ciechanover Isaac E. Chief Executive Officer 2018-09-06 Sale −1,120 $39.42 $44,150 70,378 I
Ciechanover Isaac E. Chief Executive Officer 2018-09-07 Sale −2,073 $39.74 $82,381 68,305 I
Ciechanover Isaac E. Chief Executive Officer 2018-09-07 Sale −1,827 $40.23 $73,500 66,478 I
Open-market sales · 7,800 sh · avg $39.35 · $306,923
Loading xslF345X03/doc4.xml…